CerraCap Ventures is an institutional investor (Conventional VCs) founded in 2015 and headquartered in Costa Mesa, United States. Venture capital firm industrializing innovation through investment and strategic scaling. They are founders, investors, and technologists focused on early-stage companies. They drive key customers and help scale throughout the early-stage company life cycle. The firm invests in areas like heart failure management, quantum computing, unmanned aerial systems, microbiome potential, precision diagnostics, artificial intelligence with digital avatars, data transformation, autoimmune disease solutions, and smart disinfection technologies. They aim to bridge market gaps for impact investing at scale, connecting ideas to market. They focus on enabling agile start-ups to think and act globally.

Stage

seed, early-stage venture, seed, early-stage venture

Check size

$1M-$20M

HQ

Costa Mesa, United States

Founded

2015

Website

https://www.cerracap.com/

LinkedIn

https://linkedin.com/company/cerracap-ventures

Twitter

https://twitter.com/cerracap

What they look for

B2B enterprise-grade technology startups; strong business models with global scalability potential; preference for US, Singapore, India; founders with technical depth; mission-critical technologies requiring enterprise customer access

Preparing to pitch CerraCap Ventures?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.